Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial

Familial Cancer

Volumn 4, Issue 4, 2005, Pages 279-284

  Klemp, Jennifer R ^a   O'Dea, Anne ^a   Chamberlain, Carolyn ^a   Fabian, Carol J ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

BRCA1; BRCA2; Breast cancer; Genetic testing

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EFLORNITHINE;

ADULT; ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC COUNSELING; GENETIC SCREENING; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; PATIENT SATISFACTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

BREAST NEOPLASMS; CLINICAL TRIALS, PHASE II; DISCLOSURE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MUTATION; PATIENT SATISFACTION; RISK FACTORS; TELEPHONE;

EID: 29144462042     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-005-1474-y     Document Type: Article

References (16)

1. JP Struewing C Lerman RG Kase TR Giambarresi MA Tucker 1995 Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families Cancer Epidem Biomar 4 169 73
2. Statement of the American Society of Clinical Oncology 1996 Genetic testing for cancer susceptibility J Clin Oncol 14 1730
3. CJ Isaacs BN Peshkin PB Lerman 2000 Evaluation and management of women with a strong family history of breast cancer LMJR Harris M Morrow CK Osborne Diseases of the Breast Second Edition. Williams & Wilkins Lippincott, Philadelphia 237 54
4. Huntington's Disease Society of America, I. Guidelines for Genetic Testing for Huntington's Disease, 1994.
5. RT Croyle KR Smith JR Botkin 1997 Psychological responses to BRCA1 mutation testing: Preliminary findings Health Pshchol 16 63
6. C Lerman C Hughes S Lemon 1997 Outcomes study of BRCA1/2 testing in members of hereditary breast ovarian cancer (HBOC) families Breast Cancer Res Treatm 46 10a
7. M Dorval AF Patenaude KA Schneider 2000 Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Finding from p53 and BRCA1 testing programs J Clin Oncol 18 2135 42
8. CJ Fabian BF Kimler MS Mayo 2000 Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model J Nat Cancer Inst 92 1217 27
9. CJ Fabian BF Kimler DA Brady 2002 A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers Clin Cancer Res 8 3105 17
10. MiniTab, I. MiniTab 13.
11. H Chaliki S Loader JC Levenkron 1995 Women's receptivity to testing for a genetic susceptibility to breast cancer Am J Public Health 85 1133 5
12. C Lerman C Hughes SJ Lemon 1998 What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing J Clin Oncol 16 1650
13. RT Croyle KR Smith JR Botkin 1997 Psychological responses to BRCA1 mutation testing: preliminary findings Health Psychol 16 63 72
14. KM Kash K Ortega-Verdejo MK Dabney 2000 Psychosocial aspects of cancer genetics: Women at high risk for breast and ovarian cancer Semin Surg Oncol 18 333 8
15. JC Coyne NR Benazon CG Gaba 2000 Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families J Consult Clin Psychol 68 864 74
16. EM Bleiker NK Aronson FH Menko 1997 Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family members Patient Educ Couns 32 107 16